Abbott approves $3 billion share buyback

SHARE Abbott approves $3 billion share buyback

Abbott Laboratories said Thursday its board approved spending up to $3 billion to buy back the health conglomerate’s stock.

The company, which makes Similac infant formula, medical devices and pharmaceutical drugs, said it will by stock from time to time depending on market conditions. It still has buyback authority to repurchase $511 million in shares from a buyback it announced in June 2013.

North Chicago-based Abbott also approved a dividend of 22 cents that will be paid on Nov. 15 to shareholders of record as of Oct. 15.

Abbott shares slipped 39 cents to $42.51 in afternoon trading Thursday. Its shares had risen more than 22 percent over the past year.


Abbott raises profit outlook

Abbott sells part of generic drugs business to Mylan for $5.3B

Abbott, Fonterra team up on China dairy farm

THE ASSOCIATED PRESS

The Latest
Giannoulias entrará en las elecciones generales de noviembre como el candidato favorito.
Alrededor del 20% de los votantes registrados en Chicago participaron el martes, un total no oficial que marcaría la tasa más baja de la ciudad desde 2014.
No se reportaron heridos en el incendio.
Prosecutors sought at least 25 years in prison for R. Kelly, who was convicted of sex trafficking last year in New York.